A detailed history of Knollwood Investment Advisory, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Knollwood Investment Advisory, LLC holds 31,200 shares of DXCM stock, worth $2.37 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
31,200
Previous 31,200 -0.0%
Holding current value
$2.37 Million
Previous $3.54 Billion 40.87%
% of portfolio
0.22%
Previous 0.39%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $3.11 Million - $3.96 Million
28,180 Added 933.11%
31,200 $3.54 Billion
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $227,979 - $374,963
3,020 New
3,020 $375 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Knollwood Investment Advisory, LLC Portfolio

Follow Knollwood Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knollwood Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knollwood Investment Advisory, LLC with notifications on news.